Elrose Labs Overview
- Status
- Private
- Latest Deal Type
- Accelerator/Inc
- Investors
- 1
Elrose Labs General Information
Description
Developer of a medical product designed to treat Molluscum disease. The company's product is based in a blend of phytochemical and antiviral compounds found in nature which helps to remove lesions and pain from the disease easily, enabling users to get relief from this disease within one to two weeks.
Contact Information
Website
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Pharmaceuticals
Other Industries
Drug Delivery
Primary Office
- 3875 St Johns Parkway
- Sanford, FL 32771
- United States
+1 (855) 000-0000
Elrose Labs Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Accelerator/Incubator | Completed | Startup |
Elrose Labs Executive Team (3)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| James Ragsdale | Chief Executive Officer | ||
| Sass Robert | Chief Financial Officer | ||
| Paul Konz | Chief Operating Officer |
Elrose Labs Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| University of Central Florida Business Incubator | Accelerator/Incubator | Minority | 000 0000 | 000000 0 |